Hainan Shuangcheng Pharmaceuticals Co (SZSE:002693) Total Liabilities : ¥294.8 Mil (As of Mar. 2024)

View and export this data going back to 2012. Start your Free Trial

What is Hainan Shuangcheng Pharmaceuticals Co Total Liabilities?

Hainan Shuangcheng Pharmaceuticals Co's Total Liabilities for the quarter that ended in Mar. 2024 was ¥294.8 Mil.

Hainan Shuangcheng Pharmaceuticals Co's quarterly Total Liabilities increased from Sep. 2023 (¥284.61 Mil) to Dec. 2023 (¥285.60 Mil) and increased from Dec. 2023 (¥285.60 Mil) to Mar. 2024 (¥294.77 Mil).

Hainan Shuangcheng Pharmaceuticals Co's annual Total Liabilities increased from Dec. 2021 (¥287.81 Mil) to Dec. 2022 (¥330.08 Mil) but then declined from Dec. 2022 (¥330.08 Mil) to Dec. 2023 (¥285.60 Mil).

Hainan Shuangcheng Pharmaceuticals Co Total Liabilities Historical Data

The historical data trend for Hainan Shuangcheng Pharmaceuticals Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hainan Shuangcheng Pharmaceuticals Co Total Liabilities Chart

Hainan Shuangcheng Pharmaceuticals Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

272.72

309.37

287.81

330.08

285.60

Hainan Shuangcheng Pharmaceuticals Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															309.03	312.08	284.61	285.60	294.77

Hainan Shuangcheng Pharmaceuticals Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Hainan Shuangcheng Pharmaceuticals Co's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	139.942	+	(135	+	10.661
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	285.6

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	803.248	-	517.646
	=	285.6

Hainan Shuangcheng Pharmaceuticals Co's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	129.243	+	(155.021	+	10.508
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	294.8

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	798.457	-	503.684
	=	294.8

Hainan Shuangcheng Pharmaceuticals Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Hainan Shuangcheng Pharmaceuticals Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Hainan Shuangcheng Pharmaceuticals Co (SZSE:002693) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hainan Shuangcheng Pharmaceuticals Co Ltd (SZSE:002693) » Definitions » Total Liabilities

Traded in Other Exchanges

N/A

Address

16 Xingguo Road, Xiuying District, Haikou, CHN, 570311

Website

http://www.shuangchengmed.com

Hainan Shuangcheng Pharmaceuticals Co Ltd is engaged in the research, development, and sales of synthesized peptide drugs.

Executives

Yuan Jian Lin	Executives
Zhang Wei	Executives
Yu Xiao Feng	Directors, executives
Wang Xu Guang	Executives
	Directors, executives
Wang Cheng Dong	Directors, executives
	Executives
Hu Yi	Securities Affairs Representative

Hainan Shuangcheng Pharmaceuticals Co (SZSE:002693) Headlines

No Headlines